For a decade, the argument that stopped every skeptical parent cold was simple: children who don't receive gender interventions will kill themselves. It wasn't presented as a working hypothesis or a contested finding. It was delivered as settled fact — the kind of fact that ended pediatrician conversations, legislative hearings, and dinner table debates about whether these treatments were actually safe.
Earlier this year, a major study found the mental health case underpinning that claim doesn't hold up under scrutiny. Now the Federal Trade Commission has filed suit against the organization that built it — the World Professional Association for Transgender Health, better known as WPATH — alleging it provided medical providers with the tools to make "false and unsubstantiated claims to parents" about pediatric gender transition services. The states of Alaska, Iowa, Nebraska, and Texas joined the complaint.
The FTC doesn't sue scientific organizations. It sues companies that scam consumers.
WPATH has functioned for years as the institutional backbone of the child gender-transition industry. Its guidelines gave hospitals, clinics, and activist medical providers a credentialed authority to point to when recommending puberty blockers, cross-sex hormones, and irreversible surgeries for minors. It presented itself as a professional medical body. What the FTC's complaint describes is something closer to a commercial enterprise making deceptive claims about products aimed at children.
It was activism wearing a stethoscope.
The suicide argument was the load-bearing claim — the one that made every other objection seem monstrous. Question the science, you wanted children to die. Question the methodology, you were a bigot. The emotional weight of the argument wasn't incidental; it was the mechanism by which scrutiny was suppressed. Parents who asked basic questions were told they were endangering their children. Pediatricians who raised concerns were told they were practicing hate. A debunked study sat at the center of all of it.
This lawsuit didn't emerge from nowhere. In January 2025, President Trump signed an executive order blocking federal funding for healthcare institutions performing gender operations on minors — the first domino. The FTC complaint is the enforcement arm following through, and four states lined up behind it independently. When Alaska, Iowa, Nebraska, and Texas all determine the same organization's conduct warrants their involvement, that's not a coordinated political maneuver. That's a pattern of conduct serious enough to draw consequences from multiple directions at once.
The FTC's language in the complaint is worth sitting with: WPATH gave medical providers the means to make "false and unsubstantiated claims." Not "incomplete data." Not "evolving science." False and unsubstantiated — the language of consumer fraud, not of a medical organization that made honest mistakes.
WPATH is not the American Medical Association. It is not a neutral body of dispassionate researchers. It is an advocacy organization that spent decades pushing the boundaries of what's medically and ethically permissible when it comes to children's bodies, then put the word "professional" on the letterhead to make it sound otherwise. The FTC has looked at that arrangement and called it what consumer protection law calls it.
The lab coat is coming off. Underneath it, there's nothing but a sales pitch.
